Overview

Trans Abdominis Plane (TAP) Block in Patients With Cesarean Section

Status:
Recruiting
Trial end date:
2021-04-30
Target enrollment:
0
Participant gender:
Female
Summary
Objective: To compare Trans Abdominis Plane block in providing post cesarean analgesia with control group, in terms of mean postoperative use of Opioids. Study design: Randomized controlled trial. Place and duration Department of Anesthesiology, Combined Military Hospital, Sargodha, 25th February 2021 to 25th April 2021. Materials and methods: A total of 60 female patients, who are planned to undergo elective c section and aged between 20-45 will be selected randomly and divided into two groups ( A and B) with 30pts each group. In Group A, at the end of surgery, TAP block will be given with 20ml of 0.25%bupvicaine via ultrasound guided sub-costal approach on both sides of midline. Time of TAP block will be recorded as time 0. Our outcomes will be: mean postoperative consumption of opioids and VAS score within 24hrs of surgery. Independent t test will be used to compare group A and B in terms of mean usage of tramadol within 24hrs of surgery. P value <0.05 will be considered statistically significant.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Armed Forces Hospital, Pakistan
Treatments:
Bupivacaine
Tramadol
Criteria
Inclusion Criteria:

- Age: 20 and 45 years

- Elective cesarean

- Fit to undergo surgery under spinal anesthesia

Exclusion Criteria:

Patients who will have

- Any contraindication to spinal anesthesia

- ASA class III and IV

- Known Allergic to local anesthetic

- Eclampsia

- Placenta accreta/percretra